{"id":"NCT00785785","sponsor":"Novartis Pharmaceuticals","briefTitle":"A Study of Nilotinib Versus Imatinib in GIST Patients","officialTitle":"A Randomized, Open Label, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Nilotinib Versus Imatinib in Adult Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-03","primaryCompletion":"2014-10","completion":"2014-10","firstPosted":"2008-11-05","resultsPosted":"2016-04-07","lastUpdate":"2016-06-16"},"enrollment":644,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Gastrointestinal Stromal Tumor (GIST)"],"interventions":[{"type":"DRUG","name":"Nilotinib (AMN107)","otherNames":[]},{"type":"DRUG","name":"imatinib (STI571)","otherNames":["Glivec/Gleevec"]}],"arms":[{"label":"Nilotinib","type":"EXPERIMENTAL"},{"label":"Imatinib","type":"ACTIVE_COMPARATOR"}],"summary":"This study will evaluate efficacy and safety of nilotinib versus imatinib in adult patients with unresectable or metastatic gastrointestinal stromal tumors (GIST).","primaryOutcome":{"measure":"Time to Progression Free Survival (PFS)","timeFrame":"up to month 37","effectByArm":[{"arm":"Nilotinib","deltaMin":25.9,"sd":null},{"arm":"Imatinib","deltaMin":29.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0081"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":165,"countries":["United States","Argentina","Austria","Brazil","Bulgaria","Canada","China","Colombia","Czechia","Denmark","Egypt","France","Germany","Hong Kong","Hungary","Israel","Italy","Japan","Mexico","Netherlands","Norway","Poland","Romania","Russia","Singapore","Slovakia","South Africa","South Korea","Spain","Sweden","Taiwan","Thailand","Turkey (TÃ¼rkiye)","United Kingdom","Venezuela"]},"refs":{"pmids":["25882987"],"seeAlso":["http://www.novartisclinicaltrials.com/etrials/searchTrial.do?trialID=717"]},"adverseEventsSummary":{"seriousAny":{"events":80,"n":321},"commonTop":["Nausea","Diarrhoea","Rash","Fatigue","Abdominal pain"]}}